The data offered a potential therapeutic strategy in the regulation of TF expression in BMECs in vitro and suggest that PLA NPs may be an appropriate delivery vehicle for decoy strategy in the gene therapy of cerebral thrombosis. This evidence concerns the gene TF and intracranial thrombosis.